Source: Annual Congress 2001 - Noninvasive markers of airway inflammation, bronchoprovocation, or both?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hofer, T. Rechsteiner, G. Becher, M. Rothe, R. Speich, E. W. Russi, A. Boehler (Zurich, Switzerland; Berlin, Germany). Leukotriene B₄ in exhaled breath condensate: impact of different breathing conditions during sampling. Eur Respir J 2001; 16: Suppl. 31, 1110

Member's Comments

No comment yet.

Related content which might interest you: Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006 Leukotriene B4 in exhaled breath condensate of patients after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 LTB4 and IFN-γ in exhaled breath condensate: the importance of using a nose clip Source: Eur Respir J 2007; 30: Suppl. 51, 644s Year: 2007 Exacerbation of COPD-increased markers of oxidative stress and Leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 281s Year: 2002 Influence of breathing pattern on exhaled breath condensate collection Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002 Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007 Correlation of LTB4 with α-amylase in exhaled breath condensate Source: Eur Respir J 2005; 26: Suppl. 49, 372s Year: 2005 Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010 Leukotriene B4 in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 The collection of exhaled breath condensate depends on various variables of ventilation Source: Eur Respir J 2005; 26: Suppl. 49, 261s Year: 2005 Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 680s Year: 2004 Effect of varying respiratory pattern on exhaled breath condensate collection Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Within the exhaled breath condensate (EBC), nitrite and LTB4 are correlated to each other when calculated per 100 litres exhaled breath Source: Eur Respir J 2006; 28: Suppl. 50, 789s Year: 2006